Q2 FY2026 · ended Jun 30, 2026 · Revenue $2.95M, +38.6% YoY · Filed Aug 19, 2026
Picard Medical, Inc. (PMI) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $3.0 million and a net loss of $5.7 million. Free cash flow was -$1.4 million. As of Jun 30, 2026 it held $38,000 in cash and investments and $311,000 in total debt.
Revenue
$2.95M
+38.6% vs year-ago quarter
Net income
$-5.66M
+15.8% vs year-ago quarter
Operating cash flow
$-1.35M
+71.7% vs year-ago quarter
Free cash flow
$-1.35M
+64.7% vs prior quarter
EPS
—
Dividend per share
$0.00
Shares outstanding
2.34M
-96.8% vs year-ago quarter
Net cash
$-273,000
Q2 FY2026
Operating margin
-248.1%
TTM
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PMI (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Tucson, AZ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2030617
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $3.0M | $1.1M | $1.0M | $1.2M | $2.1M |
| Operating income | -$4.6M | -$4.5M | -$3.0M | -$3.5M | -$3.5M |
| Net income | -$5.7M | -$7.6M | -$4.3M | -$10.4M | -$6.7M |
| Operating cash flow | -$1.4M | -$3.8M | -$4.4M | -$6.5M | -$4.8M |
| Free cash flow | -$1.4M | -$3.8M | — | — | — |
| Total assets | $9.2M | $11.2M | $22.5M | $13.5M | $11.7M |
| Total liabilities | $7.5M | $12.7M | $18.8M | $5.6M | $45.9M |
| Stockholders' equity | $1.7M | -$1.4M | $3.8M | $8.0M | -$54.5M |
| Cash and investments | $38,000 | $121,000 | $7.5M | $2.8M | $410,000 |
| Total debt | $311,000 | $417,000 | $527,000 | $616,000 | $429,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Nov 3, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 23, 2026 | Oct 20, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 13, 2026 | Oct 7, 2026 |
| 8-K |
Current report
New debt, Unregistered share sale
|
Oct 6, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 20, 2026 | Aug 19, 2026 |
| 10-Q | Quarterly report | Aug 19, 2026 | Jun 30, 2026 |
All 140 Picard Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.